Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor.

Rozenblum E, Sotelo-Silveira JR, Kim GY, Zhu JY, Lau CC, McNeil N, Korolevich S, Liao H, Cherry JM, Munroe DJ, Ried T, Meltzer PS, Kuehl WM, Roschke AV.

PLoS One. 2017 Aug 7;12(8):e0182610. doi: 10.1371/journal.pone.0182610. eCollection 2017.

2.

Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.

Alvarez C, Aravena A, Tapia T, Rozenblum E, Solís L, Corvalán A, Camus M, Alvarez M, Munroe D, Maass A, Carvallo P.

BMC Cancer. 2016 Mar 15;16:219. doi: 10.1186/s12885-016-2261-x.

3.

Multi-layered cancer chromosomal instability phenotype.

Roschke AV, Rozenblum E.

Front Oncol. 2013 Dec 11;3:302. doi: 10.3389/fonc.2013.00302. Review.

4.

Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Klorin G, Rozenblum E, Glebov O, Walker RL, Park Y, Meltzer PS, Kirsch IR, Kaye FJ, Roschke AV.

Cancer Genet. 2013 May;206(5):191-205. doi: 10.1016/j.cancergen.2013.04.006. Epub 2013 Jul 5.

5.

MC1R variants increase risk of melanomas harboring BRAF mutations.

Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, Peris K, Landi MT.

J Invest Dermatol. 2008 Oct;128(10):2485-90. doi: 10.1038/jid.2008.67. Epub 2008 Mar 27. Erratum in: J Invest Dermatol. 2008 Oct;128(10):2546. Fargnoli, Maria Concetia [corrected to Fargnoli, Maria Concetta].

6.
7.

Identification of molecular markers for endometriosis in blood lymphocytes by using deoxyribonucleic acid microarrays.

Flores I, Rivera E, Mousses S, Chen Y, Rozenblum E.

Fertil Steril. 2006 Jun;85(6):1676-83.

PMID:
16759924
8.

Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.

Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ.

Cancer Res. 2005 Aug 15;65(16):7137-44.

9.

Impact of DNA amplification on gene expression patterns in breast cancer.

Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringnér M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A.

Cancer Res. 2002 Nov 1;62(21):6240-5.

10.

A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes.

Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson JT, Syrjakoski K, Weaver D, Haraldsson K, Johannsdottir HK, Vehmanen P, Nigam S, Golberger N, Robbins C, Pak E, Dutra A, Gillander E, Stephan DA, Bailey-Wilson J, Juo SH, Kainu T, Arason A, Barkardottir RB, Nevanlinna H, Borg A, Kallioniemi OP.

Hum Genet. 2002 Feb;110(2):111-21. Epub 2001 Dec 14.

PMID:
11935316
11.

Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer.

Tomovska S, Richter J, Süess K, Wagner U, Rozenblum E, Gasser TC, Moch H, Mihatsch MJ, Sauter G, Schraml P.

Int J Oncol. 2001 Jun;18(6):1239-44.

PMID:
11351257
12.

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH.

Clin Cancer Res. 2001 Mar;7(3):738-44.

13.

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjäkoski K, Kuukasjärvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Grönberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhönen S, Nevanlinna H.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9603-8.

14.

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE.

Cancer Res. 1997 May 1;57(9):1731-4.

15.

INK4 genes in pancreatic carcinoma.

Rozenblum E, Schute M, Kern S.

Oncol Rep. 1996 Jul;3(4):743-5.

PMID:
21594446
16.

Mad-related genes in the human.

Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B.

Nat Genet. 1996 Jul;13(3):347-9.

PMID:
8673135
17.

Homozygous deletion map at 18q21.1 in pancreatic cancer.

Hahn SA, Hoque AT, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE.

Cancer Res. 1996 Feb 1;56(3):490-4.

18.

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.

Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE.

Science. 1996 Jan 19;271(5247):350-3.

PMID:
8553070
19.

Isolation of YAC insert sequences by representational difference analysis.

Schutte M, da Costa LT, Moskaluk CA, Rozenblum E, Guan X, de Jong PJ, Bittner M, Meltzer PS, Trent JM, Kern SE.

Nucleic Acids Res. 1995 Oct 25;23(20):4127-33.

20.

An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12.

Schutte M, Rozenblum E, Moskaluk CA, Guan X, Hoque AT, Hahn SA, da Costa LT, de Jong PJ, Kern SE.

Cancer Res. 1995 Oct 15;55(20):4570-4.

21.

Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.

Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM, et al.

Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5950-4.

22.

Interferon DNA polymorphism in chronic leukemia.

Rozenblum E, Larripa I, Barazzutti L, Rendo P, Avalos JS.

Leuk Lymphoma. 1994 Mar;13(1-2):99-103.

PMID:
7912973

Supplemental Content

Loading ...
Support Center